Morning Briefing
Summaries of health policy coverage from major news organizations
CVS Caremark To Pay $20 Million To Settle SEC Charges
The Securities and Exchange Commission had alleged that CVS did not tell investors ahead of a 2009 bond offering that it had lost "significant" Medicare Part D revenue. Elsewhere, two drugmakers are ordered to pay $9 billion in damages for failing to disclose the cancer risks for Actos, a diabetes drug.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
